MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
221 hedge funds and large institutions have $2.38B invested in Mirati Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 88 increasing their positions, 65 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
221
Holders Change
-12
Holders Change %
-5.15%
% of All Funds
3.54%
Holding in Top 10
7
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-30%
% of All Funds
0.11%
New
31
Increased
88
Reduced
65
Closed
41
Calls
$16.7M
Puts
$10.6M
Net Calls
+$6.03M
Net Calls Change
-$46.1M
Top Buyers
| 1 |
1
BlackRock
New York
|
$120M |
| 2 |
2
Marshall Wace
London,
United Kingdom
|
$20.5M |
| 3 |
3
Voloridge Investment Management
Jupiter,
Florida
|
$25.2M |
| 4 |
4
Morgan Stanley
New York
|
$76.3M |
| 5 |
5
T. Rowe Price Associates
Baltimore,
Maryland
|
$65.8M |
